Business | Wednesday September 12, 2012
Aurobindo Pharma today said it has received final approval from the US health regulator to manufacture and market generic version of anti-depressant Lexapro in the American market. The approval by the US Food & Drug Administration (USFDA) is for multiple strengths of escitalopram oxalate tablets in 5mg, 10mg and 20mg, the company said in a statemen...
www.ndtv.com/business